Trials / Sponsors / George W. Sledge Jr.
George W. Sledge Jr.
Academic / Other · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | 4-1BB Agonist Monoclonal Antibody PF-05082566 With Trastuzumab Emtansine or Trastuzumab in Treating Patients W HER2 Positive Breast Carcinoma, Recurrent Breast Carcinoma, Stage III Breast Cancer | Phase 1 | 2017-10-30 |